Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disrupting the reader of histone language.

× No keyword cloud information.

21 in total

1. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19).

Authors: C A French; I Miyoshi; J C Aster; I Kubonishi; T G Kroll; P Dal Cin; S O Vargas; A R Perez-Atayde; J A Fletcher
Journal: Am J Pathol Date: 2001-12 Impact factor: 4.307

Review 2. Bromodomain: an acetyl-lysine binding domain.

Authors: Lei Zeng; Ming Ming Zhou
Journal: FEBS Lett Date: 2002-02-20 Impact factor: 4.124

Review 3. Structure and dynamic behavior of nucleosomes.

Authors: Karolin Luger
Journal: Curr Opin Genet Dev Date: 2003-04 Impact factor: 5.578

4. Operating on chromatin, a colorful language where context matters.

Authors: Kathryn E Gardner; C David Allis; Brian D Strahl
Journal: J Mol Biol Date: 2011-01-25 Impact factor: 5.469

5. Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors: K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal: Nature Date: 1997-09-18 Impact factor: 49.962

Review 6. Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a "histone language".

Authors: Samuel S Oliver; John M Denu
Journal: Chembiochem Date: 2010-10-29 Impact factor: 3.164

7. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Authors: Christopher A French; Isao Miyoshi; Ichiro Kubonishi; Holcombe E Grier; Antonio R Perez-Atayde; Jonathan A Fletcher
Journal: Cancer Res Date: 2003-01-15 Impact factor: 12.701

8. Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution.

Authors: Friederike Vollmuth; Wulf Blankenfeldt; Matthias Geyer
Journal: J Biol Chem Date: 2009-10-13 Impact factor: 5.157

Review 9. Epigenetics in human disease and prospects for epigenetic therapy.

Authors: Gerda Egger; Gangning Liang; Ana Aparicio; Peter A Jones
Journal: Nature Date: 2004-05-27 Impact factor: 49.962

10. Selective inhibition of BET bromodomains.

Authors: Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal: Nature Date: 2010-09-24 Impact factor: 49.962

5 in total

1. Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.

Authors: Z Zou; B Huang; X Wu; H Zhang; J Qi; J Bradner; S Nair; L-F Chen
Journal: Oncogene Date: 2013-05-20 Impact factor: 9.867

Review 2. Readout of epigenetic modifications.

Authors: Dinshaw J Patel; Zhanxin Wang
Journal: Annu Rev Biochem Date: 2013 Impact factor: 23.643

Review 3. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery.

Authors: Lei-lei Fu; Mao Tian; Xiang Li; Jing-jing Li; Jian Huang; Liang Ouyang; Yonghui Zhang; Bo Liu
Journal: Oncotarget Date: 2015-03-20

4. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival.

Authors: Minji Lee; Farnoosh Tayyari; Dushanthi Pinnaduwage; Jane Bayani; John M S Bartlett; Anna Marie Mulligan; Shelley B Bull; Irene L Andrulis
Journal: BMC Cancer Date: 2018-07-20 Impact factor: 4.430

5. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.

Authors: Marie Jung; Martin Philpott; Susanne Müller; Jessica Schulze; Volker Badock; Uwe Eberspächer; Dieter Moosmayer; Benjamin Bader; Norbert Schmees; Amaury Fernández-Montalván; Bernard Haendler
Journal: J Biol Chem Date: 2014-02-04 Impact factor: 5.157

5 in total